Clinical Trial Update: Immunology and Safety of Menactra® in Children in Saudi Arabia [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating the immunology and safety of the Menactra meningococcal vaccine in children in Saudi Arabia; results were posted in 2011.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Meningitis
• Meningococcemia

Drugs mentioned

• Menactra (Meningococcal conjugate vaccine (A, C, W, Y))

Snippet

Sponsor: Sanofi Pasteur, a Sanofi Company | Conditions: Meningitis, Meningococcemia | Phase 3 | Status: COMPLETED | Results posted: 2011-01-24